Sep 22, 2025 09:03AM
Aug 25, 2025 08:01AM
Aug 25, 2025 08:00AM
Aug 20, 2025 08:01AM
Aug 20, 2025 08:00AM
Jul 31, 2025 08:06AM
Jul 31, 2025 08:05AM Evolus Announces Publication of Independent Study in JAMA Dermatology Demonstrating Jeuveau® as a Top Performer Among Leading Neurotoxins
Jun 10, 2025 08:00AM
Apr 17, 2025 05:38AM
Mar 4, 2025 04:05PM
Feb 13, 2025 01:32PM
Feb 13, 2025 01:30PM
Jan 21, 2025 08:04AM
Jan 21, 2025 08:00AM Evolus Announces Preliminary Unaudited Fourth Quarter and Full-Year 2024 Net Revenue, Achieving Record Results at the Top of the Company’s Guidance
Nov 6, 2024 04:05PM
Oct 29, 2024 08:00AM
Jul 31, 2024 04:05PM
Jun 24, 2024 08:00AM
Jun 24, 2024 08:00AM
May 20, 2024 08:31AM
May 20, 2024 08:30AM Evolus Announces Positive Data from Pivotal Trial for First Two Evolysse™ Dermal Filler Products at 2024 SCALE Meeting
May 7, 2024 04:05PM
Apr 17, 2024 04:06PM
Apr 17, 2024 04:05PM
Mar 7, 2024 04:05PM
Mar 1, 2024 08:31AM
Mar 1, 2024 08:30AM
Jan 16, 2024 05:36PM Evolus (EOLS) Reports Prelim Q4 Results
Jan 16, 2024 05:28PM
Nov 6, 2023 08:51AM
Nov 6, 2023 08:45AM
Aug 8, 2023 08:46AM
Aug 8, 2023 08:45AM
Jun 22, 2023 08:46AM
Jun 22, 2023 08:45AM Evolus Announces Successful Completion of Phase 2 Study Evaluating “Extra-Strength” Dose of Jeuveau ®
Jun 8, 2023 04:05PM
Jan 29, 2023 06:34PM
Jan 28, 2023 08:00AM
Jan 23, 2023 08:00AM
Aug 24, 2022 08:15AM
Aug 24, 2022 08:14AM
Jul 19, 2022 08:37AM Evolus Launches New Campaign Inspiring Consumers to “Switch Your Tox and Love Evolus Forever”
Jul 12, 2022 08:47AM
Jun 2, 2022 08:55AM
Jun 2, 2022 08:54AM
May 18, 2022 08:15AM
May 11, 2022 08:45AM
May 10, 2022 04:05PM
Apr 26, 2022 08:45AM Evolus to Report First Quarter 2022 Results and Provide Business Update
Mar 31, 2022 08:15AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All